TUCATINIB

N/A

Manufactured by SEAGEN INC.

Last updated: 2026-04-15

About TUCATINIB

TUCATINIB is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by SEAGEN INC.. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for TUCATINIB.

Report Outcomes

Out of 6,507 classified reports for TUCATINIB:

Serious 65.3%Non-Serious 34.7%

The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.

Demographics Breakdown

Reports by Age

Age 66138 reports
Age 65122 reports
Age 47111 reports
Age 57109 reports
Age 59102 reports
Age 6199 reports
Age 5898 reports
Age 5588 reports
Age 6787 reports
Age 7286 reports
Age 6083 reports
Age 6482 reports
Age 7079 reports
Age 6878 reports
Age 5277 reports
Age 5677 reports
Age 6373 reports
Age 5472 reports
Age 6271 reports
Age 5068 reports

Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.

Frequently Asked Questions

Who manufactures TUCATINIB?

Labeling and FAERS entries often list SEAGEN INC. in connection with TUCATINIB. Always verify the specific product and NDC with your pharmacist.

Important Disclaimer: This content is generated by AI analysis of FDA adverse event reports and is provided for informational purposes only. It is not medical advice. Adverse event reports submitted to the FDA do not prove that a medication caused the reported side effect. Always consult your healthcare provider before starting, stopping, or changing any medication. If you experience a serious side effect, contact your doctor or call 911 immediately.